Search Result "hypodopaminergia"
Hypodopaminergia and âPrecision Behavioral Managementâ (PBM): It is a Generational Family Affair
Journal: Current Pharmaceutical Biotechnology
Volume: 21 Issue: 6 Year: 2020 Page: 528-541
Author(s): Lyle Fried,Edward J. Modestino,David Siwicki,Lisa Lott,Panayotis K. Thanos,David Baron,Rajendra D. Badgaiyan,Jessica V. Ponce,James Giordano,William B. Downs,Marjorie C. Gondré-Lewis,Steinberg Bruce,Eric R. Braverman,Brent Boyett,Kenneth Blum
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) during Adolescent Brain Development
Journal: Current Psychopharmacology
Volume: 10 Issue: 3 Year: 2021 Page: 181-196
Author(s): Kenneth Blum,Abdalla Bowirrat,Marjorie C.G. Lewis,Thomas A. Simpatico,Mauro Ceccanti,Bruce Steinberg,Edward J. Modestino,Panayotis K. Thanos,David Baron,Thomas McLaughlin,Raymond Brewer,Rajendra D. Badgaiyan,Jessica V. Ponce,Lisa Lott,Mark S. Gold
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The âHoly Grailâ in Genetic Addiction Risk Testing
Journal: Current Psychopharmacology
Volume: 9 Issue: 1 Year: 2020 Page: 7-21
Author(s): Kenneth Blum,David Baron,Lisa Lott,Jessica V. Ponce,David Siwicki,Brent Boyett,Bruce Steinberg,Edward J. Modestino,Lyle Fried,Mary Hauser,Thomas Simpatico,Bill W. Downs,Thomas McLaughlin,Raju Hajela,Rajendra D. Badgaiyan
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia
Journal: Current Psychopharmacology
Volume: 9 Issue: 3 Year: 2020 Page: 164-184
Author(s): Raymond Brewer,Kenneth Blum,Abdalla Bowirrat,Edward J. Modestino,David Baron,Rajendra D. Badgaiyan,Mark Moran,Brent Boyett,Mark S. Gold
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Journal: Current Psychopharmacology
Volume: 10 Issue: 2 Year: 2021 Page: 86-97
Author(s): Kenneth Blum,Edward J. Modestino,David Baron,Raymond Brewer,Panayotis Thanos,Igor Elman,Rajendra D. Badgaiyan,B. William Downs,Debasis Bagchi,Thomas McLaughlin,Abdalla Bowirrat,A. Kenison Roy,Mark S. Gold
Preface [Hot topic: Pharmacological Treatment of Schizophrenia: Recent Antipsychotic Drugs and New Therapeutic Strategies Guest Editor: Maria Augusta Raggi ]
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2004 Page: i-i
Author(s): Maria Augusta Raggi
Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Journal: Current Psychiatry Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 111-119
Author(s): Stephan C. Mann, Stanley N. Caroff, Gabor S. Ungvari, E. Cabrina Campbell
D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment
Journal: Current Signal Transduction Therapy
Volume: 8 Issue: 2 Year: 2013 Page: 119-128
Author(s): Felice Iasevoli,Livia Avvisati,Gianmarco Latte,Elisabetta F. Buonaguro,Carmine Tomasetti,Luigi Aloj,Andrea de Bartolomeis
Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 2 Year: 2007 Page: 141-149
Author(s): Phil Skolnick, Anthony S. Basile